nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—SLC6A3—bipolar disorder	0.315	0.377	CbGaD
Escitalopram—HTR2C—bipolar disorder	0.284	0.341	CbGaD
Escitalopram—SLC6A4—bipolar disorder	0.236	0.282	CbGaD
Escitalopram—SLC6A2—locus ceruleus—bipolar disorder	0.0104	0.184	CbGeAlD
Escitalopram—SLC6A3—telencephalic ventricle—bipolar disorder	0.00609	0.108	CbGeAlD
Escitalopram—HTR2C—telencephalic ventricle—bipolar disorder	0.00588	0.104	CbGeAlD
Escitalopram—SLC6A2—autonomic nervous system—bipolar disorder	0.0055	0.0977	CbGeAlD
Escitalopram—CYP2C19—urine—bipolar disorder	0.00422	0.075	CbGeAlD
Escitalopram—Citalopram—SLC6A3—bipolar disorder	0.00273	0.377	CrCbGaD
Escitalopram—SLC6A4—blood plasma—bipolar disorder	0.00266	0.0472	CbGeAlD
Escitalopram—CYP3A4—urine—bipolar disorder	0.0025	0.0443	CbGeAlD
Escitalopram—Citalopram—HTR2C—bipolar disorder	0.00246	0.34	CrCbGaD
Escitalopram—CYP2D6—urine—bipolar disorder	0.00246	0.0436	CbGeAlD
Escitalopram—CYP2C19—blood plasma—bipolar disorder	0.0022	0.0391	CbGeAlD
Escitalopram—Citalopram—SLC6A4—bipolar disorder	0.00204	0.282	CrCbGaD
Escitalopram—CYP3A4—blood plasma—bipolar disorder	0.0013	0.0231	CbGeAlD
Escitalopram—CYP2D6—blood plasma—bipolar disorder	0.00128	0.0228	CbGeAlD
Escitalopram—SLC6A3—nervous system—bipolar disorder	0.000863	0.0153	CbGeAlD
Escitalopram—HTR2C—nervous system—bipolar disorder	0.000834	0.0148	CbGeAlD
Escitalopram—SLC6A3—cerebellum—bipolar disorder	0.000812	0.0144	CbGeAlD
Escitalopram—SLC6A4—nervous system—bipolar disorder	0.000791	0.014	CbGeAlD
Escitalopram—CHRM1—nervous system—bipolar disorder	0.000788	0.014	CbGeAlD
Escitalopram—SLC6A2—nervous system—bipolar disorder	0.000696	0.0124	CbGeAlD
Escitalopram—SLC6A3—brain—bipolar disorder	0.00066	0.0117	CbGeAlD
Escitalopram—ADRA1A—nervous system—bipolar disorder	0.000647	0.0115	CbGeAlD
Escitalopram—HTR2C—brain—bipolar disorder	0.000638	0.0113	CbGeAlD
Escitalopram—ADRA1A—cerebellum—bipolar disorder	0.000609	0.0108	CbGeAlD
Escitalopram—SLC6A4—brain—bipolar disorder	0.000604	0.0107	CbGeAlD
Escitalopram—CHRM1—brain—bipolar disorder	0.000602	0.0107	CbGeAlD
Escitalopram—SLC6A2—brain—bipolar disorder	0.000532	0.00945	CbGeAlD
Escitalopram—HRH1—nervous system—bipolar disorder	0.000501	0.0089	CbGeAlD
Escitalopram—ADRA1A—brain—bipolar disorder	0.000495	0.00878	CbGeAlD
Escitalopram—CYP3A4—nervous system—bipolar disorder	0.000387	0.00688	CbGeAlD
Escitalopram—HRH1—brain—bipolar disorder	0.000383	0.0068	CbGeAlD
Escitalopram—CYP2D6—nervous system—bipolar disorder	0.000381	0.00677	CbGeAlD
Escitalopram—CYP2D6—cerebellum—bipolar disorder	0.000359	0.00637	CbGeAlD
Escitalopram—CYP2D6—brain—bipolar disorder	0.000291	0.00517	CbGeAlD
Escitalopram—HTR2C—Signaling Pathways—DRD5—bipolar disorder	3.58e-05	0.000352	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—MAOA—bipolar disorder	3.57e-05	0.000352	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—POMC—bipolar disorder	3.56e-05	0.00035	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	3.55e-05	0.000349	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	3.54e-05	0.000348	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR1A—bipolar disorder	3.53e-05	0.000348	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—DRD4—bipolar disorder	3.53e-05	0.000348	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	3.52e-05	0.000347	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RGS4—bipolar disorder	3.51e-05	0.000346	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TAC1—bipolar disorder	3.48e-05	0.000343	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—HTR2A—bipolar disorder	3.47e-05	0.000342	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—IMPA1—bipolar disorder	3.46e-05	0.00034	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD1—bipolar disorder	3.41e-05	0.000336	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DGKH—bipolar disorder	3.39e-05	0.000334	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DGKH—bipolar disorder	3.38e-05	0.000333	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	3.38e-05	0.000333	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	3.37e-05	0.000332	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	3.36e-05	0.000331	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DGKH—bipolar disorder	3.33e-05	0.000328	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—ADCY2—bipolar disorder	3.33e-05	0.000327	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	3.32e-05	0.000327	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	3.31e-05	0.000326	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR1A—bipolar disorder	3.31e-05	0.000326	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD3—bipolar disorder	3.31e-05	0.000325	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—DRD2—bipolar disorder	3.29e-05	0.000324	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—TAC1—bipolar disorder	3.26e-05	0.000321	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—POMC—bipolar disorder	3.26e-05	0.000321	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	3.26e-05	0.000321	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	3.26e-05	0.000321	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	3.25e-05	0.00032	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	3.25e-05	0.00032	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD4—bipolar disorder	3.21e-05	0.000316	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2C—bipolar disorder	3.2e-05	0.000315	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD1—bipolar disorder	3.2e-05	0.000315	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—IMPA1—bipolar disorder	3.18e-05	0.000313	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	3.15e-05	0.000311	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	3.14e-05	0.00031	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD5—bipolar disorder	3.1e-05	0.000305	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD3—bipolar disorder	3.1e-05	0.000305	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD5—bipolar disorder	3.09e-05	0.000304	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.08e-05	0.000303	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	3.06e-05	0.000301	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	3.06e-05	0.000301	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	3.05e-05	0.000301	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	3.05e-05	0.0003	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD5—bipolar disorder	3.04e-05	0.0003	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RGS4—bipolar disorder	3.04e-05	0.000299	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RGS4—bipolar disorder	3.03e-05	0.000299	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—ADCY2—bipolar disorder	3.02e-05	0.000297	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TAC1—bipolar disorder	3.02e-05	0.000297	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	3.01e-05	0.000296	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR1A—bipolar disorder	3e-05	0.000296	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD4—bipolar disorder	3e-05	0.000296	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD2—bipolar disorder	2.99e-05	0.000294	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RGS4—bipolar disorder	2.98e-05	0.000294	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TAC1—bipolar disorder	2.96e-05	0.000291	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	2.96e-05	0.000291	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—DRD1—bipolar disorder	2.96e-05	0.000291	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	2.95e-05	0.00029	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	2.95e-05	0.00029	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NDUFV2—bipolar disorder	2.94e-05	0.000289	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2C—bipolar disorder	2.9e-05	0.000286	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD1—bipolar disorder	2.9e-05	0.000286	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	2.88e-05	0.000284	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	2.87e-05	0.000283	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—DRD3—bipolar disorder	2.86e-05	0.000282	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	2.86e-05	0.000281	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	2.85e-05	0.000281	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKR1C4—bipolar disorder	2.85e-05	0.00028	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	2.84e-05	0.00028	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—ADCY2—bipolar disorder	2.83e-05	0.000278	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—POMC—bipolar disorder	2.82e-05	0.000278	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—POMC—bipolar disorder	2.81e-05	0.000277	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD3—bipolar disorder	2.81e-05	0.000277	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD2—bipolar disorder	2.8e-05	0.000276	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—DRD4—bipolar disorder	2.78e-05	0.000274	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	2.77e-05	0.000273	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—POMC—bipolar disorder	2.77e-05	0.000273	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD4—bipolar disorder	2.73e-05	0.000269	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TRPC3—bipolar disorder	2.71e-05	0.000267	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NDUFV2—bipolar disorder	2.7e-05	0.000266	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKR1C4—bipolar disorder	2.62e-05	0.000258	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	2.62e-05	0.000258	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	2.61e-05	0.000257	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—DRD2—bipolar disorder	2.59e-05	0.000255	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADM—bipolar disorder	2.59e-05	0.000255	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	2.58e-05	0.000254	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	2.57e-05	0.000253	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NR1D1—bipolar disorder	2.56e-05	0.000252	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	2.54e-05	0.00025	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TSHB—bipolar disorder	2.52e-05	0.000248	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	2.52e-05	0.000248	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TACR1—bipolar disorder	2.52e-05	0.000248	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NCAN—bipolar disorder	2.45e-05	0.000241	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SLC5A3—bipolar disorder	2.4e-05	0.000236	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NR1D1—bipolar disorder	2.35e-05	0.000232	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TRPC3—bipolar disorder	2.35e-05	0.000231	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	2.34e-05	0.000231	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.32e-05	0.000229	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	2.31e-05	0.000227	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	2.31e-05	0.000227	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NCAN—bipolar disorder	2.25e-05	0.000221	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADM—bipolar disorder	2.24e-05	0.000221	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADM—bipolar disorder	2.24e-05	0.00022	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.2e-05	0.000217	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADM—bipolar disorder	2.2e-05	0.000217	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TSHB—bipolar disorder	2.19e-05	0.000215	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PDE4B—bipolar disorder	2.19e-05	0.000215	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TACR1—bipolar disorder	2.19e-05	0.000215	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TSHB—bipolar disorder	2.18e-05	0.000214	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TACR1—bipolar disorder	2.18e-05	0.000214	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	2.18e-05	0.000214	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	2.14e-05	0.000211	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	2.14e-05	0.000211	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	2.14e-05	0.000211	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	2.09e-05	0.000206	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	2.09e-05	0.000206	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.08e-05	0.000205	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TAC1—bipolar disorder	2.06e-05	0.000202	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD1—bipolar disorder	2.02e-05	0.000198	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	2e-05	0.000197	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	1.99e-05	0.000196	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.96e-05	0.000193	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.96e-05	0.000193	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.95e-05	0.000192	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.94e-05	0.000191	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.9e-05	0.000187	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.84e-05	0.000181	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	1.81e-05	0.000179	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR1A—bipolar disorder	1.81e-05	0.000178	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	1.81e-05	0.000178	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	1.8e-05	0.000178	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	1.78e-05	0.000176	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TAC1—bipolar disorder	1.78e-05	0.000175	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	1.78e-05	0.000175	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	1.78e-05	0.000175	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TAC1—bipolar disorder	1.78e-05	0.000175	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	1.78e-05	0.000175	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.77e-05	0.000174	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD2—bipolar disorder	1.77e-05	0.000174	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	1.75e-05	0.000172	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2C—bipolar disorder	1.75e-05	0.000172	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD1—bipolar disorder	1.75e-05	0.000172	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD1—bipolar disorder	1.74e-05	0.000171	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	1.74e-05	0.000171	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CLOCK—bipolar disorder	1.73e-05	0.000171	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	1.71e-05	0.000169	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	1.71e-05	0.000169	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.71e-05	0.000169	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK2—bipolar disorder	1.7e-05	0.000167	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	1.69e-05	0.000167	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD3—bipolar disorder	1.69e-05	0.000167	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TSHB—bipolar disorder	1.69e-05	0.000166	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPH2—bipolar disorder	1.69e-05	0.000166	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CACNB2—bipolar disorder	1.69e-05	0.000166	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD3—bipolar disorder	1.69e-05	0.000166	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GSK3A—bipolar disorder	1.68e-05	0.000166	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	1.68e-05	0.000165	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—POMC—bipolar disorder	1.67e-05	0.000165	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	1.67e-05	0.000164	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—DPYD—bipolar disorder	1.66e-05	0.000164	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	1.66e-05	0.000163	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	1.65e-05	0.000163	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD4—bipolar disorder	1.64e-05	0.000162	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD4—bipolar disorder	1.64e-05	0.000161	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	1.61e-05	0.000159	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	1.6e-05	0.000157	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—bipolar disorder	1.6e-05	0.000157	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.59e-05	0.000157	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	1.59e-05	0.000157	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	1.57e-05	0.000154	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.55e-05	0.000153	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TSHB—bipolar disorder	1.55e-05	0.000153	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.55e-05	0.000153	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPH2—bipolar disorder	1.55e-05	0.000153	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADCY2—bipolar disorder	1.55e-05	0.000152	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CACNA1C—bipolar disorder	1.54e-05	0.000152	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	1.54e-05	0.000152	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	1.54e-05	0.000152	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.54e-05	0.000151	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	1.54e-05	0.000151	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD2—bipolar disorder	1.53e-05	0.000151	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—DPYD—bipolar disorder	1.53e-05	0.00015	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD2—bipolar disorder	1.53e-05	0.00015	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	1.52e-05	0.000149	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	1.51e-05	0.000149	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	1.5e-05	0.000148	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	1.5e-05	0.000148	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.48e-05	0.000146	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NCAN—bipolar disorder	1.47e-05	0.000145	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—bipolar disorder	1.45e-05	0.000143	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—bipolar disorder	1.44e-05	0.000142	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.44e-05	0.000142	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	1.42e-05	0.00014	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.42e-05	0.00014	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK1—bipolar disorder	1.39e-05	0.000136	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.38e-05	0.000136	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	1.38e-05	0.000136	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NRG1—bipolar disorder	1.37e-05	0.000135	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	1.36e-05	0.000134	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SNAP25—bipolar disorder	1.35e-05	0.000133	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—S100B—bipolar disorder	1.35e-05	0.000133	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—S100B—bipolar disorder	1.34e-05	0.000132	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—S100B—bipolar disorder	1.32e-05	0.00013	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.24e-05	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	1.24e-05	0.000122	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADCY2—bipolar disorder	1.19e-05	0.000118	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NRG1—bipolar disorder	1.19e-05	0.000117	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NRG1—bipolar disorder	1.18e-05	0.000117	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	1.17e-05	0.000115	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.1e-05	0.000108	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—bipolar disorder	1.07e-05	0.000106	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	1.07e-05	0.000105	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	1.05e-05	0.000104	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.04e-05	0.000103	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—COMT—bipolar disorder	1.02e-05	0.000101	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MAOA—bipolar disorder	1.02e-05	0.0001	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TSHB—bipolar disorder	1.02e-05	9.99e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPH2—bipolar disorder	1.02e-05	9.99e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.02e-05	9.99e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DPYD—bipolar disorder	9.99e-06	9.83e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	9.96e-06	9.8e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—bipolar disorder	9.88e-06	9.72e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—INS—bipolar disorder	9.82e-06	9.67e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—COMT—bipolar disorder	9.41e-06	9.26e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MAOA—bipolar disorder	9.34e-06	9.2e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNA1C—bipolar disorder	9.28e-06	9.14e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	9.05e-06	8.91e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GSK3B—bipolar disorder	8.63e-06	8.49e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	8.6e-06	8.47e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—bipolar disorder	8.56e-06	8.43e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—bipolar disorder	8.53e-06	8.4e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—INS—bipolar disorder	8.51e-06	8.38e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—INS—bipolar disorder	8.48e-06	8.35e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	8.47e-06	8.34e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—bipolar disorder	8.4e-06	8.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—INS—bipolar disorder	8.35e-06	8.22e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—bipolar disorder	8.27e-06	8.14e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SNAP25—bipolar disorder	8.12e-06	7.99e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—bipolar disorder	7.6e-06	7.49e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADCY2—bipolar disorder	7.18e-06	7.07e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—bipolar disorder	6.61e-06	6.51e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INS—bipolar disorder	6.58e-06	6.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—COMT—bipolar disorder	6.15e-06	6.06e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MAOA—bipolar disorder	6.11e-06	6.01e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—bipolar disorder	6.08e-06	5.99e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INS—bipolar disorder	6.05e-06	5.95e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—bipolar disorder	4.97e-06	4.89e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—bipolar disorder	3.98e-06	3.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INS—bipolar disorder	3.95e-06	3.89e-05	CbGpPWpGaD
